Cargando…
Understanding astrocyte differentiation: Clinical relevance, technical challenges, and new opportunities in the omics era
Astrocytes are a major type of glial cells that have essential functions in development and homeostasis of the central nervous system (CNS). Immature astrocytes in the developing CNS support neuronal maturation and possess neural‐stem‐cell‐like properties. Mature astrocytes partially lose these func...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539907/ https://www.ncbi.nlm.nih.gov/pubmed/35546493 http://dx.doi.org/10.1002/wsbm.1557 |
_version_ | 1784803593661972480 |
---|---|
author | Lattke, Michael Guillemot, Francois |
author_facet | Lattke, Michael Guillemot, Francois |
author_sort | Lattke, Michael |
collection | PubMed |
description | Astrocytes are a major type of glial cells that have essential functions in development and homeostasis of the central nervous system (CNS). Immature astrocytes in the developing CNS support neuronal maturation and possess neural‐stem‐cell‐like properties. Mature astrocytes partially lose these functions but gain new functions essential for adult CNS homeostasis. In pathological conditions, astrocytes become “reactive”, which disrupts their mature homeostatic functions and reactivates some immature astrocyte‐like properties, suggesting a partial reversal of astrocyte maturation. The loss of homeostatic astrocyte functions contributes to the pathogenesis of various neurological conditions, and therefore activating maturation‐promoting mechanisms may be a promising therapeutic strategy to restore homeostasis. Manipulating the mechanisms underlying astrocyte maturation might also allow to facilitate CNS regeneration by enhancing developmental functions of adult astrocytes. However, such therapeutic strategies are still some distance away because of our limited understanding of astrocyte differentiation and maturation, due to biological and technical challenges, including the high degree of similarity of astrocytes with neural stem cells and the shortcomings of astrocyte markers. Current advances in systems biology have a huge potential to overcome these challenges. Recent transcriptomic analyses have already revealed new astrocyte markers and new regulators of astrocyte differentiation. However, the epigenomic changes that presumably occur during astrocyte differentiation remain an important, largely unexplored area for future research. Emerging technologies such as CRISPR/Cas9‐based functional screens will further improve our understanding of the mechanisms underlying astrocyte differentiation. This may open up new clinical approaches to restore homeostasis in neurological disorders and/or promote CNS regeneration. This article is categorized under: Neurological Diseases > Genetics/Genomics/Epigenetics. Neurological Diseases > Stem Cells and Development. Neurological Diseases > Molecular and Cellular Physiology. |
format | Online Article Text |
id | pubmed-9539907 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95399072022-10-14 Understanding astrocyte differentiation: Clinical relevance, technical challenges, and new opportunities in the omics era Lattke, Michael Guillemot, Francois WIREs Mech Dis Advanced Reviews Astrocytes are a major type of glial cells that have essential functions in development and homeostasis of the central nervous system (CNS). Immature astrocytes in the developing CNS support neuronal maturation and possess neural‐stem‐cell‐like properties. Mature astrocytes partially lose these functions but gain new functions essential for adult CNS homeostasis. In pathological conditions, astrocytes become “reactive”, which disrupts their mature homeostatic functions and reactivates some immature astrocyte‐like properties, suggesting a partial reversal of astrocyte maturation. The loss of homeostatic astrocyte functions contributes to the pathogenesis of various neurological conditions, and therefore activating maturation‐promoting mechanisms may be a promising therapeutic strategy to restore homeostasis. Manipulating the mechanisms underlying astrocyte maturation might also allow to facilitate CNS regeneration by enhancing developmental functions of adult astrocytes. However, such therapeutic strategies are still some distance away because of our limited understanding of astrocyte differentiation and maturation, due to biological and technical challenges, including the high degree of similarity of astrocytes with neural stem cells and the shortcomings of astrocyte markers. Current advances in systems biology have a huge potential to overcome these challenges. Recent transcriptomic analyses have already revealed new astrocyte markers and new regulators of astrocyte differentiation. However, the epigenomic changes that presumably occur during astrocyte differentiation remain an important, largely unexplored area for future research. Emerging technologies such as CRISPR/Cas9‐based functional screens will further improve our understanding of the mechanisms underlying astrocyte differentiation. This may open up new clinical approaches to restore homeostasis in neurological disorders and/or promote CNS regeneration. This article is categorized under: Neurological Diseases > Genetics/Genomics/Epigenetics. Neurological Diseases > Stem Cells and Development. Neurological Diseases > Molecular and Cellular Physiology. John Wiley & Sons, Inc. 2022-05-12 2022 /pmc/articles/PMC9539907/ /pubmed/35546493 http://dx.doi.org/10.1002/wsbm.1557 Text en © 2022 The Authors. WIREs Mechanisms of Disease published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Advanced Reviews Lattke, Michael Guillemot, Francois Understanding astrocyte differentiation: Clinical relevance, technical challenges, and new opportunities in the omics era |
title | Understanding astrocyte differentiation: Clinical relevance, technical challenges, and new opportunities in the omics era |
title_full | Understanding astrocyte differentiation: Clinical relevance, technical challenges, and new opportunities in the omics era |
title_fullStr | Understanding astrocyte differentiation: Clinical relevance, technical challenges, and new opportunities in the omics era |
title_full_unstemmed | Understanding astrocyte differentiation: Clinical relevance, technical challenges, and new opportunities in the omics era |
title_short | Understanding astrocyte differentiation: Clinical relevance, technical challenges, and new opportunities in the omics era |
title_sort | understanding astrocyte differentiation: clinical relevance, technical challenges, and new opportunities in the omics era |
topic | Advanced Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539907/ https://www.ncbi.nlm.nih.gov/pubmed/35546493 http://dx.doi.org/10.1002/wsbm.1557 |
work_keys_str_mv | AT lattkemichael understandingastrocytedifferentiationclinicalrelevancetechnicalchallengesandnewopportunitiesintheomicsera AT guillemotfrancois understandingastrocytedifferentiationclinicalrelevancetechnicalchallengesandnewopportunitiesintheomicsera |